The OncoAlert Newsletter is NOW OUT Click to Register
The OncoAlert Newsletter is now out for June 23-29, 2023
The OncoAlert Newsletter is now out for June 23-29, 2023
Although the sample size for this trial was small, data still highlight a potential benefit with nivolumab in dMMR uterine and ovarian cancers.
Two studies provide new insights on the effects of vaginal oestrogen therapy and physical exercise to tackle sexual impairment
The Video Journal of Oncology (VJOncology) is an independent, global, open-access video journal, dedicated to providing trusted and up-to-date information in order to improve the…
SNB-101 has received FDA fast track designation for potential use in patients with small cell lung cancer.
Following positive response data from the phase II TRANSCEND FL study, lisocabtagene maraleucel receives accelerated U.S. FDA approval for the treatment of adult patients with…
The Video Journal of Oncology (VJOncology) is an independent, global, open-access video journal, dedicated to providing trusted and up-to-date information in order to improve the…
Prolonged administration of imatinib maintenance therapy for 6 years improved disease-free survival in patients with gastrointestinal stromal tumors.
We are happy to inform you that the ESMO 2023 Virtual Mentorship Programme is officially underway!
On May 16, 2024, the FDA granted accelerated approval to tarlatamab-dlle (Imdelltra, Amgen, Inc.) for extensive stage small cell lung cancer.
A survey of 1284 American patients with cancer has shown the extent of cancer-related medical debt in the USA.